All articles tagged with #uk regulation
Britain’s summer recess leaves Paramount’s $110B takeover of Warner Bros. Discovery in limbo as Culture Secretary Lisa Nandy weighs a public‑interest intervention; CMA investigations continue and Ofcom could be drawn in, potentially pushing a decision past September and complicating closing timelines under the UK merger regime.
A BBC InDepth investigation shows the UK’s cosmetic injectables boom—especially non-surgical liquid BBLs—has grown far faster than regulation, with deaths and serious harm from unregulated clinics, prescription medicines sold without proper checks, and counterfeit products; enforcement is fragmented and licensing reforms promised for England and Scotland have not yet been fully put in place, leaving patients at risk while authorities grapple with how to regulate the industry.
WIRED reports a London clinic run by Alastair Jessel that treats stage-4 cancer by sealing patients naked in a plastic bag and exposing them to chlorine dioxide gas. There is no credible evidence this is safe or effective, and UK regulators say chlorine dioxide has no medical authorization; the Cancer Act 1939 bars nonmedical advertising of cancer cures. The clinic faced investigations by the FSA and Trading Standards, while regulators note enforcement is limited and critics warn vulnerable patients are being exploited.
UK regulators (the CMA) order Google to add clearer source attribution and links to content used in AI-generated search results and to allow publishers to opt out of AI features; Google must implement new controls (including directory- and page-level opt-outs) and publish compliance reports within nine months, with testing in the UK before a potential global rollout.
UK financial authorities including the Bank of England, FCA and HM Treasury are in urgent talks with the National Cyber Security Centre to assess cyber risks from Anthropic’s Mythos, warning major banks, insurers and markets as the model reportedly uncovered thousands of high-severity vulnerabilities and as regulators consider standardized AI-model monitoring for lenders.
OpenAI is pausing Stargate UK amid regulatory uncertainty and high energy costs, delaying the planned deployment of thousands of GPUs with Nvidia and Nscale; the company says it will reassess once regulation and energy prices make long-term infrastructure investment viable. The pause comes as UK policy debates over AI copyright and data use slow changes to the regulatory environment, even as OpenAI maintains its UK presence and aims to advance public-sector AI initiatives under its government MOU.
Pornhub will restrict UK access for users who haven’t completed age verification under the Online Safety Act, arguing the law pushes users to non-compliant sites and raises safety concerns; critics see it as a potential tactic to press lawmakers or boost registrations, while VPNs continue to complicate enforcement and overall UK traffic trends remain uncertain.
UK regulators have strengthened warnings that rare but severe pancreatitis, including necrotizing cases, has been reported in users of GLP-1/GIP obesity and diabetes drugs Wegovy and Mounjaro. The MHRA cites about 1,300 reports from 2007–Oct 2025, including 19 deaths and 24 necrotizing pancreatitis, across roughly 25 million packs dispensed. Doctors are advised to monitor patients and patients with severe persistent abdominal pain should seek medical care; clinicians should check for drug use, especially if purchased privately. Novo Nordisk and Eli Lilly say the overall benefit-risk remains positive and safety is being monitored.
Britain's Ofcom has opened an investigation into Elon Musk's X to assess whether it complies with the Online Safety Act amid reports that Grok, its AI chatbot, is creating non-consensual and sexualized deepfakes of women and children.
The UK government is urging Ofcom to decide within days whether to ban Elon Musk's platform X due to non-compliance with laws, amid concerns over Grok AI being used to create sexualized deepfake images, with calls for stricter regulation and potential access restrictions.
The UK's largest retail investment platform, Hargreaves Lansdowne, warns investors that cryptocurrencies like Bitcoin are not true asset classes and are highly volatile, advising caution despite recent regulatory changes allowing crypto ETNs in tax-free accounts. While some institutional interest remains, the firm emphasizes the risks and lack of intrinsic value in cryptocurrencies, urging investors to consider these factors carefully.
Shares of Alphabet (GOOGL) declined amid UK regulatory threats targeting its mobile ecosystem, as the CMA plans to designate Google and Apple with strategic market status, potentially leading to regulatory actions to increase competition and consumer choice. Despite regulatory pressures, GOOGL remains a strong buy with a consensus price target of $206.51, indicating nearly 8% upside.
The UK is lagging behind other countries like Singapore, Abu Dhabi, and the US in establishing a regulatory framework for stablecoins, risking its competitiveness in financial innovation. While the US advances with the Genius Act and the USDC stablecoin, the UK remains bogged down in bureaucratic delays and risk aversion, missing a key opportunity to lead in blockchain and digital currencies. The author advocates for adopting a more dynamic, light-touch regulatory approach, similar to those in Abu Dhabi and Singapore, to foster innovation and maintain global competitiveness.